nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—TGM2—esophageal cancer	0.736	1	CbGaD
L-Glutamine—TGM4—epithelium—esophageal cancer	0.00505	0.0431	CbGeAlD
L-Glutamine—TGM6—lung—esophageal cancer	0.00423	0.0361	CbGeAlD
L-Glutamine—TGM2—neck—esophageal cancer	0.00305	0.026	CbGeAlD
L-Glutamine—QARS—neck—esophageal cancer	0.0024	0.0205	CbGeAlD
L-Glutamine—TGM5—lung—esophageal cancer	0.00222	0.019	CbGeAlD
L-Glutamine—TGM1—digestive system—esophageal cancer	0.00215	0.0184	CbGeAlD
L-Glutamine—GLUL—exocrine gland—esophageal cancer	0.00209	0.0178	CbGeAlD
L-Glutamine—TGM2—epithelium—esophageal cancer	0.00207	0.0177	CbGeAlD
L-Glutamine—TGM3—digestive system—esophageal cancer	0.00202	0.0172	CbGeAlD
L-Glutamine—TGM2—smooth muscle tissue—esophageal cancer	0.002	0.0171	CbGeAlD
L-Glutamine—GMPS—bronchus—esophageal cancer	0.00192	0.0164	CbGeAlD
L-Glutamine—CTPS1—bronchus—esophageal cancer	0.00192	0.0164	CbGeAlD
L-Glutamine—GFPT2—bronchus—esophageal cancer	0.00189	0.0161	CbGeAlD
L-Glutamine—GFPT2—smooth muscle tissue—esophageal cancer	0.00185	0.0158	CbGeAlD
L-Glutamine—GLS2—digestive system—esophageal cancer	0.00185	0.0158	CbGeAlD
L-Glutamine—NADSYN1—digestive system—esophageal cancer	0.00185	0.0158	CbGeAlD
L-Glutamine—TGM2—trachea—esophageal cancer	0.00183	0.0157	CbGeAlD
L-Glutamine—TGM1—lung—esophageal cancer	0.0018	0.0154	CbGeAlD
L-Glutamine—SLC7A8—neck—esophageal cancer	0.00171	0.0146	CbGeAlD
L-Glutamine—PFAS—trachea—esophageal cancer	0.0017	0.0145	CbGeAlD
L-Glutamine—GFPT2—trachea—esophageal cancer	0.0017	0.0145	CbGeAlD
L-Glutamine—F13A1—bronchus—esophageal cancer	0.00169	0.0145	CbGeAlD
L-Glutamine—TGM3—lung—esophageal cancer	0.00169	0.0144	CbGeAlD
L-Glutamine—QARS—bronchus—esophageal cancer	0.00161	0.0138	CbGeAlD
L-Glutamine—GLS—digestive system—esophageal cancer	0.0016	0.0136	CbGeAlD
L-Glutamine—TGM2—digestive system—esophageal cancer	0.00158	0.0135	CbGeAlD
L-Glutamine—QARS—smooth muscle tissue—esophageal cancer	0.00158	0.0135	CbGeAlD
L-Glutamine—NADSYN1—lung—esophageal cancer	0.00154	0.0132	CbGeAlD
L-Glutamine—GLS2—lung—esophageal cancer	0.00154	0.0132	CbGeAlD
L-Glutamine—F13A1—trachea—esophageal cancer	0.00152	0.013	CbGeAlD
L-Glutamine—CTPS1—digestive system—esophageal cancer	0.00149	0.0127	CbGeAlD
L-Glutamine—GMPS—digestive system—esophageal cancer	0.00149	0.0127	CbGeAlD
L-Glutamine—QARS—trachea—esophageal cancer	0.00145	0.0123	CbGeAlD
L-Glutamine—Glutathione—GLO1—esophageal cancer	0.00144	0.258	CrCbGaD
L-Glutamine—GATB—lung—esophageal cancer	0.00141	0.0121	CbGeAlD
L-Glutamine—CCBL1—lung—esophageal cancer	0.00141	0.0121	CbGeAlD
L-Glutamine—GLUL—neck—esophageal cancer	0.00133	0.0114	CbGeAlD
L-Glutamine—GLS—lung—esophageal cancer	0.00133	0.0114	CbGeAlD
L-Glutamine—TGM2—lung—esophageal cancer	0.00132	0.0112	CbGeAlD
L-Glutamine—F13A1—digestive system—esophageal cancer	0.00131	0.0112	CbGeAlD
L-Glutamine—SLC1A5—epithelium—esophageal cancer	0.0013	0.0111	CbGeAlD
L-Glutamine—Glutathione—GSTO1—esophageal cancer	0.00128	0.23	CrCbGaD
L-Glutamine—SLC1A5—bronchus—esophageal cancer	0.00128	0.0109	CbGeAlD
L-Glutamine—SLC1A5—smooth muscle tissue—esophageal cancer	0.00125	0.0107	CbGeAlD
L-Glutamine—QARS—digestive system—esophageal cancer	0.00124	0.0106	CbGeAlD
L-Glutamine—GMPS—lung—esophageal cancer	0.00124	0.0106	CbGeAlD
L-Glutamine—CTPS1—lung—esophageal cancer	0.00124	0.0106	CbGeAlD
L-Glutamine—TGM1—lymph node—esophageal cancer	0.00123	0.0105	CbGeAlD
L-Glutamine—GFPT2—lung—esophageal cancer	0.00122	0.0104	CbGeAlD
L-Glutamine—PFAS—lung—esophageal cancer	0.00122	0.0104	CbGeAlD
L-Glutamine—SLC1A5—trachea—esophageal cancer	0.00115	0.00978	CbGeAlD
L-Glutamine—ASNS—bronchus—esophageal cancer	0.00109	0.00934	CbGeAlD
L-Glutamine—F13A1—lung—esophageal cancer	0.00109	0.00933	CbGeAlD
L-Glutamine—ASNS—smooth muscle tissue—esophageal cancer	0.00107	0.00914	CbGeAlD
L-Glutamine—GLS2—lymph node—esophageal cancer	0.00105	0.009	CbGeAlD
L-Glutamine—NADSYN1—lymph node—esophageal cancer	0.00105	0.009	CbGeAlD
L-Glutamine—QARS—lung—esophageal cancer	0.00104	0.00887	CbGeAlD
L-Glutamine—SLC16A10—neck—esophageal cancer	0.00102	0.00868	CbGeAlD
L-Glutamine—SLC1A5—digestive system—esophageal cancer	0.000986	0.00841	CbGeAlD
L-Glutamine—ASNS—trachea—esophageal cancer	0.000983	0.00839	CbGeAlD
L-Glutamine—CCBL1—lymph node—esophageal cancer	0.000967	0.00826	CbGeAlD
L-Glutamine—GATB—lymph node—esophageal cancer	0.000967	0.00826	CbGeAlD
L-Glutamine—CAD—lung—esophageal cancer	0.000958	0.00818	CbGeAlD
L-Glutamine—GLS—lymph node—esophageal cancer	0.000911	0.00778	CbGeAlD
L-Glutamine—GLUL—epithelium—esophageal cancer	0.000908	0.00775	CbGeAlD
L-Glutamine—Proctalgia—Capecitabine—esophageal cancer	0.000907	0.0335	CcSEcCtD
L-Glutamine—GLUL—bronchus—esophageal cancer	0.000894	0.00763	CbGeAlD
L-Glutamine—PPAT—lung—esophageal cancer	0.000889	0.00759	CbGeAlD
L-Glutamine—GLUL—smooth muscle tissue—esophageal cancer	0.000875	0.00747	CbGeAlD
L-Glutamine—GMPS—lymph node—esophageal cancer	0.000849	0.00725	CbGeAlD
L-Glutamine—CTPS1—lymph node—esophageal cancer	0.000849	0.00725	CbGeAlD
L-Glutamine—GFPT2—lymph node—esophageal cancer	0.000833	0.00711	CbGeAlD
L-Glutamine—PFAS—lymph node—esophageal cancer	0.000833	0.00711	CbGeAlD
L-Glutamine—SLC1A5—lung—esophageal cancer	0.000823	0.00703	CbGeAlD
L-Glutamine—GLUL—trachea—esophageal cancer	0.000803	0.00685	CbGeAlD
L-Glutamine—F13A1—lymph node—esophageal cancer	0.000748	0.00638	CbGeAlD
L-Glutamine—SLC7A8—lung—esophageal cancer	0.000741	0.00633	CbGeAlD
L-Glutamine—Gastric ulcer—Capecitabine—esophageal cancer	0.000732	0.027	CcSEcCtD
L-Glutamine—Haemorrhoids—Capecitabine—esophageal cancer	0.000723	0.0267	CcSEcCtD
L-Glutamine—QARS—lymph node—esophageal cancer	0.000711	0.00607	CbGeAlD
L-Glutamine—ASNS—lung—esophageal cancer	0.000706	0.00603	CbGeAlD
L-Glutamine—Infection—Carboplatin—esophageal cancer	0.000697	0.0257	CcSEcCtD
L-Glutamine—SLC16A10—epithelium—esophageal cancer	0.000692	0.00591	CbGeAlD
L-Glutamine—GLUL—digestive system—esophageal cancer	0.000691	0.0059	CbGeAlD
L-Glutamine—Bacterial infection—Methotrexate—esophageal cancer	0.000686	0.0253	CcSEcCtD
L-Glutamine—Nail disorder—Capecitabine—esophageal cancer	0.000656	0.0242	CcSEcCtD
L-Glutamine—CAD—lymph node—esophageal cancer	0.000656	0.0056	CbGeAlD
L-Glutamine—PPAT—lymph node—esophageal cancer	0.000608	0.00519	CbGeAlD
L-Glutamine—Pain—Carboplatin—esophageal cancer	0.0006	0.0222	CcSEcCtD
L-Glutamine—Laryngitis—Capecitabine—esophageal cancer	0.00059	0.0218	CcSEcCtD
L-Glutamine—GLUL—lung—esophageal cancer	0.000577	0.00492	CbGeAlD
L-Glutamine—L-Arginine—NOS3—esophageal cancer	0.000568	0.102	CrCbGaD
L-Glutamine—SLC1A5—lymph node—esophageal cancer	0.000563	0.00481	CbGeAlD
L-Glutamine—Body temperature increased—Carboplatin—esophageal cancer	0.000555	0.0205	CcSEcCtD
L-Glutamine—Fungal infection—Capecitabine—esophageal cancer	0.000551	0.0203	CcSEcCtD
L-Glutamine—L-Arginine—NOS2—esophageal cancer	0.000549	0.0984	CrCbGaD
L-Glutamine—Rigors—Capecitabine—esophageal cancer	0.000521	0.0192	CcSEcCtD
L-Glutamine—Injection site pain—Capecitabine—esophageal cancer	0.000521	0.0192	CcSEcCtD
L-Glutamine—SLC7A8—lymph node—esophageal cancer	0.000507	0.00433	CbGeAlD
L-Glutamine—Glutathione—GSTT1—esophageal cancer	0.000499	0.0894	CrCbGaD
L-Glutamine—Nail disorder—Methotrexate—esophageal cancer	0.000488	0.018	CcSEcCtD
L-Glutamine—L-Citrulline—NOS3—esophageal cancer	0.000483	0.0866	CrCbGaD
L-Glutamine—ASNS—lymph node—esophageal cancer	0.000483	0.00412	CbGeAlD
L-Glutamine—L-Citrulline—NOS2—esophageal cancer	0.000467	0.0836	CrCbGaD
L-Glutamine—SLC16A10—lung—esophageal cancer	0.00044	0.00375	CbGeAlD
L-Glutamine—Injection site reaction—Capecitabine—esophageal cancer	0.000423	0.0156	CcSEcCtD
L-Glutamine—Fungal infection—Methotrexate—esophageal cancer	0.00041	0.0151	CcSEcCtD
L-Glutamine—Candida infection—Capecitabine—esophageal cancer	0.000406	0.015	CcSEcCtD
L-Glutamine—GLUL—lymph node—esophageal cancer	0.000394	0.00337	CbGeAlD
L-Glutamine—Dehydration—Cisplatin—esophageal cancer	0.00039	0.0144	CcSEcCtD
L-Glutamine—Sepsis—Capecitabine—esophageal cancer	0.000369	0.0136	CcSEcCtD
L-Glutamine—Pancreatitis—Cisplatin—esophageal cancer	0.000355	0.0131	CcSEcCtD
L-Glutamine—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000353	0.013	CcSEcCtD
L-Glutamine—Sweating increased—Cisplatin—esophageal cancer	0.000353	0.013	CcSEcCtD
L-Glutamine—Thirst—Capecitabine—esophageal cancer	0.000324	0.012	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000316	0.0117	CcSEcCtD
L-Glutamine—SLC16A10—lymph node—esophageal cancer	0.000301	0.00257	CbGeAlD
L-Glutamine—Glutathione—ABCC2—esophageal cancer	0.000288	0.0517	CrCbGaD
L-Glutamine—Dehydration—Capecitabine—esophageal cancer	0.000287	0.0106	CcSEcCtD
L-Glutamine—Urinary tract disorder—Cisplatin—esophageal cancer	0.000286	0.0106	CcSEcCtD
L-Glutamine—Urethral disorder—Cisplatin—esophageal cancer	0.000284	0.0105	CcSEcCtD
L-Glutamine—Sepsis—Methotrexate—esophageal cancer	0.000275	0.0101	CcSEcCtD
L-Glutamine—Abdominal distension—Capecitabine—esophageal cancer	0.000269	0.00992	CcSEcCtD
L-Glutamine—Sweating increased—Capecitabine—esophageal cancer	0.00026	0.0096	CcSEcCtD
L-Glutamine—Malnutrition—Cisplatin—esophageal cancer	0.000252	0.00931	CcSEcCtD
L-Glutamine—Flatulence—Cisplatin—esophageal cancer	0.000249	0.00918	CcSEcCtD
L-Glutamine—Depression—Capecitabine—esophageal cancer	0.000237	0.00876	CcSEcCtD
L-Glutamine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000234	0.00864	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000233	0.00861	CcSEcCtD
L-Glutamine—Malaise—Cisplatin—esophageal cancer	0.000227	0.0084	CcSEcCtD
L-Glutamine—Myalgia—Cisplatin—esophageal cancer	0.000215	0.00793	CcSEcCtD
L-Glutamine—Rhinitis—Capecitabine—esophageal cancer	0.000214	0.00791	CcSEcCtD
L-Glutamine—Discomfort—Cisplatin—esophageal cancer	0.000212	0.00783	CcSEcCtD
L-Glutamine—Pharyngitis—Capecitabine—esophageal cancer	0.000212	0.00783	CcSEcCtD
L-Glutamine—Urinary tract disorder—Capecitabine—esophageal cancer	0.000211	0.00779	CcSEcCtD
L-Glutamine—Urethral disorder—Capecitabine—esophageal cancer	0.000209	0.00773	CcSEcCtD
L-Glutamine—Oedema—Cisplatin—esophageal cancer	0.000206	0.0076	CcSEcCtD
L-Glutamine—Infection—Cisplatin—esophageal cancer	0.000205	0.00755	CcSEcCtD
L-Glutamine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000199	0.00735	CcSEcCtD
L-Glutamine—Pancreatitis—Methotrexate—esophageal cancer	0.000195	0.00719	CcSEcCtD
L-Glutamine—Angiopathy—Capecitabine—esophageal cancer	0.000194	0.00716	CcSEcCtD
L-Glutamine—Chills—Capecitabine—esophageal cancer	0.000192	0.00708	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000188	0.00692	CcSEcCtD
L-Glutamine—Mental disorder—Capecitabine—esophageal cancer	0.000187	0.00691	CcSEcCtD
L-Glutamine—Malnutrition—Capecitabine—esophageal cancer	0.000186	0.00687	CcSEcCtD
L-Glutamine—Flatulence—Capecitabine—esophageal cancer	0.000183	0.00676	CcSEcCtD
L-Glutamine—Back pain—Capecitabine—esophageal cancer	0.00018	0.00664	CcSEcCtD
L-Glutamine—Depression—Methotrexate—esophageal cancer	0.000177	0.00652	CcSEcCtD
L-Glutamine—Pain—Cisplatin—esophageal cancer	0.000176	0.0065	CcSEcCtD
L-Glutamine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000173	0.00637	CcSEcCtD
L-Glutamine—Feeling abnormal—Cisplatin—esophageal cancer	0.00017	0.00626	CcSEcCtD
L-Glutamine—Malaise—Capecitabine—esophageal cancer	0.000168	0.00619	CcSEcCtD
L-Glutamine—Body temperature increased—Cisplatin—esophageal cancer	0.000163	0.00601	CcSEcCtD
L-Glutamine—Chest pain—Capecitabine—esophageal cancer	0.000158	0.00584	CcSEcCtD
L-Glutamine—Myalgia—Capecitabine—esophageal cancer	0.000158	0.00584	CcSEcCtD
L-Glutamine—Arthralgia—Capecitabine—esophageal cancer	0.000158	0.00584	CcSEcCtD
L-Glutamine—Pharyngitis—Methotrexate—esophageal cancer	0.000158	0.00583	CcSEcCtD
L-Glutamine—Urinary tract disorder—Methotrexate—esophageal cancer	0.000157	0.0058	CcSEcCtD
L-Glutamine—Discomfort—Capecitabine—esophageal cancer	0.000156	0.00577	CcSEcCtD
L-Glutamine—Urethral disorder—Methotrexate—esophageal cancer	0.000156	0.00575	CcSEcCtD
L-Glutamine—Dry mouth—Capecitabine—esophageal cancer	0.000155	0.00572	CcSEcCtD
L-Glutamine—Oedema—Capecitabine—esophageal cancer	0.000152	0.0056	CcSEcCtD
L-Glutamine—Hypersensitivity—Cisplatin—esophageal cancer	0.000152	0.0056	CcSEcCtD
L-Glutamine—Infection—Capecitabine—esophageal cancer	0.000151	0.00557	CcSEcCtD
L-Glutamine—Asthenia—Cisplatin—esophageal cancer	0.000148	0.00545	CcSEcCtD
L-Glutamine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000147	0.00542	CcSEcCtD
L-Glutamine—Angiopathy—Methotrexate—esophageal cancer	0.000144	0.00533	CcSEcCtD
L-Glutamine—Chills—Methotrexate—esophageal cancer	0.000143	0.00527	CcSEcCtD
L-Glutamine—Mental disorder—Methotrexate—esophageal cancer	0.000139	0.00514	CcSEcCtD
L-Glutamine—Malnutrition—Methotrexate—esophageal cancer	0.000138	0.00511	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000138	0.0051	CcSEcCtD
L-Glutamine—Insomnia—Capecitabine—esophageal cancer	0.000137	0.00507	CcSEcCtD
L-Glutamine—Back pain—Methotrexate—esophageal cancer	0.000134	0.00494	CcSEcCtD
L-Glutamine—Vomiting—Cisplatin—esophageal cancer	0.000131	0.00483	CcSEcCtD
L-Glutamine—Fatigue—Capecitabine—esophageal cancer	0.000131	0.00483	CcSEcCtD
L-Glutamine—Rash—Cisplatin—esophageal cancer	0.00013	0.00479	CcSEcCtD
L-Glutamine—Constipation—Capecitabine—esophageal cancer	0.00013	0.00479	CcSEcCtD
L-Glutamine—Pain—Capecitabine—esophageal cancer	0.00013	0.00479	CcSEcCtD
L-Glutamine—Dermatitis—Cisplatin—esophageal cancer	0.00013	0.00479	CcSEcCtD
L-Glutamine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000128	0.00474	CcSEcCtD
L-Glutamine—Feeling abnormal—Capecitabine—esophageal cancer	0.000125	0.00462	CcSEcCtD
L-Glutamine—Malaise—Methotrexate—esophageal cancer	0.000125	0.00461	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000124	0.00458	CcSEcCtD
L-Glutamine—Nausea—Cisplatin—esophageal cancer	0.000122	0.00451	CcSEcCtD
L-Glutamine—Abdominal pain—Capecitabine—esophageal cancer	0.00012	0.00443	CcSEcCtD
L-Glutamine—Body temperature increased—Capecitabine—esophageal cancer	0.00012	0.00443	CcSEcCtD
L-Glutamine—Chest pain—Methotrexate—esophageal cancer	0.000118	0.00435	CcSEcCtD
L-Glutamine—Myalgia—Methotrexate—esophageal cancer	0.000118	0.00435	CcSEcCtD
L-Glutamine—Arthralgia—Methotrexate—esophageal cancer	0.000118	0.00435	CcSEcCtD
L-Glutamine—Discomfort—Methotrexate—esophageal cancer	0.000116	0.0043	CcSEcCtD
L-Glutamine—Infection—Methotrexate—esophageal cancer	0.000112	0.00414	CcSEcCtD
L-Glutamine—Hypersensitivity—Capecitabine—esophageal cancer	0.000112	0.00413	CcSEcCtD
L-Glutamine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000109	0.00403	CcSEcCtD
L-Glutamine—Asthenia—Capecitabine—esophageal cancer	0.000109	0.00402	CcSEcCtD
L-Glutamine—Pruritus—Capecitabine—esophageal cancer	0.000107	0.00396	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000103	0.0038	CcSEcCtD
L-Glutamine—Insomnia—Methotrexate—esophageal cancer	0.000102	0.00377	CcSEcCtD
L-Glutamine—Dizziness—Capecitabine—esophageal cancer	0.0001	0.00371	CcSEcCtD
L-Glutamine—Fatigue—Methotrexate—esophageal cancer	9.74e-05	0.0036	CcSEcCtD
L-Glutamine—Pain—Methotrexate—esophageal cancer	9.66e-05	0.00357	CcSEcCtD
L-Glutamine—Vomiting—Capecitabine—esophageal cancer	9.65e-05	0.00356	CcSEcCtD
L-Glutamine—Rash—Capecitabine—esophageal cancer	9.57e-05	0.00353	CcSEcCtD
L-Glutamine—Dermatitis—Capecitabine—esophageal cancer	9.56e-05	0.00353	CcSEcCtD
L-Glutamine—Headache—Capecitabine—esophageal cancer	9.51e-05	0.00351	CcSEcCtD
L-Glutamine—Feeling abnormal—Methotrexate—esophageal cancer	9.31e-05	0.00344	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Methotrexate—esophageal cancer	9.24e-05	0.00341	CcSEcCtD
L-Glutamine—Nausea—Capecitabine—esophageal cancer	9.01e-05	0.00333	CcSEcCtD
L-Glutamine—Abdominal pain—Methotrexate—esophageal cancer	8.93e-05	0.0033	CcSEcCtD
L-Glutamine—Body temperature increased—Methotrexate—esophageal cancer	8.93e-05	0.0033	CcSEcCtD
L-Glutamine—Hypersensitivity—Methotrexate—esophageal cancer	8.32e-05	0.00307	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—PSME1—esophageal cancer	8.22e-05	0.000717	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—SMAD4—esophageal cancer	8.22e-05	0.000716	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—TYMP—esophageal cancer	8.18e-05	0.000713	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CA2—esophageal cancer	8.18e-05	0.000713	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CA2—esophageal cancer	8.18e-05	0.000713	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ALDH2—esophageal cancer	8.18e-05	0.000713	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ALDH2—esophageal cancer	8.18e-05	0.000713	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ALDH2—esophageal cancer	8.18e-05	0.000713	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—CYP19A1—esophageal cancer	8.18e-05	0.000713	CbGpPWpGaD
L-Glutamine—Asthenia—Methotrexate—esophageal cancer	8.11e-05	0.00299	CcSEcCtD
L-Glutamine—CAD—Metabolism—TPI1—esophageal cancer	8.09e-05	0.000705	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GSTO1—esophageal cancer	8.09e-05	0.000705	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	8.04e-05	0.000701	CbGpPWpGaD
L-Glutamine—Pruritus—Methotrexate—esophageal cancer	7.99e-05	0.00295	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—CREBBP—esophageal cancer	7.98e-05	0.000696	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—FBXW7—esophageal cancer	7.97e-05	0.000694	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CYP26A1—esophageal cancer	7.96e-05	0.000694	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—HSPA5—esophageal cancer	7.93e-05	0.000691	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	7.8e-05	0.00068	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—GSTT1—esophageal cancer	7.78e-05	0.000678	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—GSTT1—esophageal cancer	7.78e-05	0.000678	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—GSTT1—esophageal cancer	7.78e-05	0.000678	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ALOX15—esophageal cancer	7.76e-05	0.000676	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CYP1B1—esophageal cancer	7.76e-05	0.000676	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ALDOB—esophageal cancer	7.76e-05	0.000676	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CYP1B1—esophageal cancer	7.76e-05	0.000676	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CYP2A6—esophageal cancer	7.69e-05	0.000671	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CYP2A6—esophageal cancer	7.69e-05	0.000671	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CYP2A6—esophageal cancer	7.69e-05	0.000671	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CALR—esophageal cancer	7.69e-05	0.00067	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ADH7—esophageal cancer	7.61e-05	0.000663	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ADH7—esophageal cancer	7.61e-05	0.000663	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PLCE1—esophageal cancer	7.61e-05	0.000663	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PLCE1—esophageal cancer	7.61e-05	0.000663	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—GHRL—esophageal cancer	7.56e-05	0.000659	CbGpPWpGaD
L-Glutamine—Dizziness—Methotrexate—esophageal cancer	7.47e-05	0.00276	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—HMOX1—esophageal cancer	7.47e-05	0.000651	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GAPDH—esophageal cancer	7.47e-05	0.000651	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—FBXW7—esophageal cancer	7.43e-05	0.000648	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GSTO1—esophageal cancer	7.4e-05	0.000645	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—TPI1—esophageal cancer	7.4e-05	0.000645	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CRABP1—esophageal cancer	7.4e-05	0.000645	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—TGFBR2—esophageal cancer	7.37e-05	0.000642	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CYP19A1—esophageal cancer	7.29e-05	0.000636	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CYP19A1—esophageal cancer	7.29e-05	0.000636	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTGS1—esophageal cancer	7.29e-05	0.000636	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTGS1—esophageal cancer	7.29e-05	0.000636	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ENO1—esophageal cancer	7.29e-05	0.000636	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ENO1—esophageal cancer	7.29e-05	0.000636	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTGS1—esophageal cancer	7.29e-05	0.000636	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ENO1—esophageal cancer	7.29e-05	0.000636	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PSME2—esophageal cancer	7.19e-05	0.000626	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PSME2—esophageal cancer	7.19e-05	0.000626	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PSME1—esophageal cancer	7.19e-05	0.000626	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PSME1—esophageal cancer	7.19e-05	0.000626	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PSME2—esophageal cancer	7.19e-05	0.000626	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PSME1—esophageal cancer	7.19e-05	0.000626	CbGpPWpGaD
L-Glutamine—Vomiting—Methotrexate—esophageal cancer	7.18e-05	0.00265	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—ABCB1—esophageal cancer	7.17e-05	0.000625	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—NOS3—esophageal cancer	7.15e-05	0.000623	CbGpPWpGaD
L-Glutamine—Rash—Methotrexate—esophageal cancer	7.12e-05	0.00263	CcSEcCtD
L-Glutamine—Dermatitis—Methotrexate—esophageal cancer	7.12e-05	0.00263	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—CYP1B1—esophageal cancer	7.09e-05	0.000618	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ALDOB—esophageal cancer	7.09e-05	0.000618	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—ABL1—esophageal cancer	7.08e-05	0.000617	CbGpPWpGaD
L-Glutamine—Headache—Methotrexate—esophageal cancer	7.08e-05	0.00261	CcSEcCtD
L-Glutamine—CAD—Metabolism—GNG7—esophageal cancer	7.04e-05	0.000613	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—SMAD4—esophageal cancer	6.98e-05	0.000608	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GAPDH—esophageal cancer	6.83e-05	0.000595	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CRABP1—esophageal cancer	6.77e-05	0.00059	CbGpPWpGaD
L-Glutamine—Nausea—Methotrexate—esophageal cancer	6.71e-05	0.00248	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—CYP19A1—esophageal cancer	6.67e-05	0.000581	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ADH1B—esophageal cancer	6.67e-05	0.000581	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ADH1B—esophageal cancer	6.67e-05	0.000581	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—HMOX1—esophageal cancer	6.66e-05	0.00058	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—HMOX1—esophageal cancer	6.66e-05	0.00058	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ALDH2—esophageal cancer	6.6e-05	0.000575	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.49e-05	0.000565	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—TGFBR2—esophageal cancer	6.44e-05	0.000561	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GNG7—esophageal cancer	6.44e-05	0.000561	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—ABCB1—esophageal cancer	6.39e-05	0.000557	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—ABCB1—esophageal cancer	6.39e-05	0.000557	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—TYMP—esophageal cancer	6.38e-05	0.000556	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—TYMP—esophageal cancer	6.38e-05	0.000556	CbGpPWpGaD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—CREBBP—esophageal cancer	6.32e-05	0.000551	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GSTT1—esophageal cancer	6.27e-05	0.000547	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CYP1B1—esophageal cancer	6.2e-05	0.00054	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CYP1B1—esophageal cancer	6.2e-05	0.00054	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CYP1B1—esophageal cancer	6.2e-05	0.00054	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CYP2A6—esophageal cancer	6.2e-05	0.00054	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP26A1—esophageal cancer	6.2e-05	0.00054	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP26A1—esophageal cancer	6.2e-05	0.00054	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.19e-05	0.000539	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—SMAD4—esophageal cancer	6.1e-05	0.000531	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—HMOX1—esophageal cancer	6.09e-05	0.000531	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—NOTCH1—esophageal cancer	6.06e-05	0.000528	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ALOX15—esophageal cancer	6.04e-05	0.000527	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ALOX15—esophageal cancer	6.04e-05	0.000527	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ALDH2—esophageal cancer	6.03e-05	0.000526	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.94e-05	0.000517	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.89e-05	0.000513	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTGS1—esophageal cancer	5.88e-05	0.000512	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ENO1—esophageal cancer	5.88e-05	0.000512	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—ABCB1—esophageal cancer	5.84e-05	0.000509	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CYP19A1—esophageal cancer	5.83e-05	0.000508	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CYP19A1—esophageal cancer	5.83e-05	0.000508	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CYP19A1—esophageal cancer	5.83e-05	0.000508	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PSME1—esophageal cancer	5.79e-05	0.000505	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PSME2—esophageal cancer	5.79e-05	0.000505	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—TPI1—esophageal cancer	5.77e-05	0.000502	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GSTO1—esophageal cancer	5.77e-05	0.000502	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—TPI1—esophageal cancer	5.77e-05	0.000502	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GSTO1—esophageal cancer	5.77e-05	0.000502	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GSTT1—esophageal cancer	5.74e-05	0.0005	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HIF1A—esophageal cancer	5.71e-05	0.000497	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CYP2A6—esophageal cancer	5.67e-05	0.000494	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ALDOB—esophageal cancer	5.53e-05	0.000482	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ALDOB—esophageal cancer	5.53e-05	0.000482	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—CREBBP—esophageal cancer	5.49e-05	0.000479	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—EP300—esophageal cancer	5.44e-05	0.000474	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ENO1—esophageal cancer	5.38e-05	0.000469	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTGS1—esophageal cancer	5.38e-05	0.000469	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.37e-05	0.000468	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—HMOX1—esophageal cancer	5.32e-05	0.000464	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—HMOX1—esophageal cancer	5.32e-05	0.000464	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—HMOX1—esophageal cancer	5.32e-05	0.000464	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GAPDH—esophageal cancer	5.32e-05	0.000464	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GAPDH—esophageal cancer	5.32e-05	0.000464	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PSME2—esophageal cancer	5.3e-05	0.000462	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PSME1—esophageal cancer	5.3e-05	0.000462	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CRABP1—esophageal cancer	5.27e-05	0.00046	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CRABP1—esophageal cancer	5.27e-05	0.00046	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NOS2—esophageal cancer	5.19e-05	0.000453	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NOTCH1—esophageal cancer	5.14e-05	0.000448	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ABCB1—esophageal cancer	5.11e-05	0.000445	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ABCB1—esophageal cancer	5.11e-05	0.000445	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ABCB1—esophageal cancer	5.11e-05	0.000445	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—NOS2—esophageal cancer	5.1e-05	0.000445	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GNG7—esophageal cancer	5.02e-05	0.000437	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GNG7—esophageal cancer	5.02e-05	0.000437	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CYP1B1—esophageal cancer	5e-05	0.000436	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HIF1A—esophageal cancer	4.99e-05	0.000435	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—CREBBP—esophageal cancer	4.79e-05	0.000417	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CYP19A1—esophageal cancer	4.7e-05	0.00041	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ALDH2—esophageal cancer	4.7e-05	0.00041	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ALDH2—esophageal cancer	4.7e-05	0.00041	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CREBBP—esophageal cancer	4.66e-05	0.000406	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—CREBBP—esophageal cancer	4.58e-05	0.000399	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CYP1B1—esophageal cancer	4.57e-05	0.000398	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NOS2—esophageal cancer	4.54e-05	0.000396	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NOTCH1—esophageal cancer	4.5e-05	0.000392	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GSTT1—esophageal cancer	4.47e-05	0.00039	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GSTT1—esophageal cancer	4.47e-05	0.00039	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP2A6—esophageal cancer	4.42e-05	0.000385	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP2A6—esophageal cancer	4.42e-05	0.000385	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CYP19A1—esophageal cancer	4.3e-05	0.000375	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—HMOX1—esophageal cancer	4.29e-05	0.000374	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—NOS3—esophageal cancer	4.29e-05	0.000374	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CREBBP—esophageal cancer	4.27e-05	0.000372	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CREBBP—esophageal cancer	4.27e-05	0.000372	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTGS1—esophageal cancer	4.19e-05	0.000365	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTGS1—esophageal cancer	4.19e-05	0.000365	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ENO1—esophageal cancer	4.19e-05	0.000365	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ENO1—esophageal cancer	4.19e-05	0.000365	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NOS3—esophageal cancer	4.17e-05	0.000364	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PSME2—esophageal cancer	4.13e-05	0.00036	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PSME1—esophageal cancer	4.13e-05	0.00036	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PSME1—esophageal cancer	4.13e-05	0.00036	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PSME2—esophageal cancer	4.13e-05	0.00036	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ABCB1—esophageal cancer	4.12e-05	0.000359	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—NOS3—esophageal cancer	4.1e-05	0.000358	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CREBBP—esophageal cancer	4.08e-05	0.000355	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—PIK3CA—esophageal cancer	4.02e-05	0.00035	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.97e-05	0.000346	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTGS2—esophageal cancer	3.92e-05	0.000342	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—HMOX1—esophageal cancer	3.92e-05	0.000342	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—CREBBP—esophageal cancer	3.9e-05	0.00034	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—ERBB2—esophageal cancer	3.9e-05	0.00034	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—esophageal cancer	3.89e-05	0.000339	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—NOS3—esophageal cancer	3.82e-05	0.000333	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—NOS3—esophageal cancer	3.82e-05	0.000333	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTGS2—esophageal cancer	3.82e-05	0.000333	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ABCB1—esophageal cancer	3.76e-05	0.000328	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NOS3—esophageal cancer	3.65e-05	0.000318	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.59e-05	0.000313	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP1B1—esophageal cancer	3.56e-05	0.00031	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP1B1—esophageal cancer	3.56e-05	0.00031	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—NOS3—esophageal cancer	3.5e-05	0.000305	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTGS2—esophageal cancer	3.5e-05	0.000305	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTGS2—esophageal cancer	3.5e-05	0.000305	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.44e-05	0.0003	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CREBBP—esophageal cancer	3.41e-05	0.000297	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CREBBP—esophageal cancer	3.41e-05	0.000297	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CREBBP—esophageal cancer	3.41e-05	0.000297	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—ERBB2—esophageal cancer	3.41e-05	0.000297	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP19A1—esophageal cancer	3.35e-05	0.000292	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP19A1—esophageal cancer	3.35e-05	0.000292	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTGS2—esophageal cancer	3.34e-05	0.000291	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CDKN1A—esophageal cancer	3.34e-05	0.000291	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—EP300—esophageal cancer	3.26e-05	0.000284	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—MYC—esophageal cancer	3.26e-05	0.000284	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTGS2—esophageal cancer	3.2e-05	0.000279	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EP300—esophageal cancer	3.18e-05	0.000277	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—EP300—esophageal cancer	3.12e-05	0.000272	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—NOS3—esophageal cancer	3.06e-05	0.000266	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—NOS3—esophageal cancer	3.06e-05	0.000266	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—NOS3—esophageal cancer	3.06e-05	0.000266	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—HMOX1—esophageal cancer	3.06e-05	0.000266	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—HMOX1—esophageal cancer	3.06e-05	0.000266	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ABCB1—esophageal cancer	2.93e-05	0.000256	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ABCB1—esophageal cancer	2.93e-05	0.000256	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CDKN1A—esophageal cancer	2.92e-05	0.000254	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—EP300—esophageal cancer	2.91e-05	0.000253	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—EP300—esophageal cancer	2.91e-05	0.000253	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTGS2—esophageal cancer	2.79e-05	0.000244	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTGS2—esophageal cancer	2.79e-05	0.000244	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTGS2—esophageal cancer	2.79e-05	0.000244	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EP300—esophageal cancer	2.78e-05	0.000242	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MYC—esophageal cancer	2.77e-05	0.000241	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CREBBP—esophageal cancer	2.75e-05	0.00024	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EGFR—esophageal cancer	2.71e-05	0.000236	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—EP300—esophageal cancer	2.66e-05	0.000232	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CREBBP—esophageal cancer	2.52e-05	0.000219	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—NOS3—esophageal cancer	2.46e-05	0.000215	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MYC—esophageal cancer	2.42e-05	0.000211	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3CA—esophageal cancer	2.41e-05	0.00021	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EGFR—esophageal cancer	2.37e-05	0.000206	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PIK3CA—esophageal cancer	2.35e-05	0.000205	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—EP300—esophageal cancer	2.32e-05	0.000203	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—EP300—esophageal cancer	2.32e-05	0.000203	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—EP300—esophageal cancer	2.32e-05	0.000203	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3CA—esophageal cancer	2.31e-05	0.000201	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.3e-05	0.000201	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—NOS3—esophageal cancer	2.25e-05	0.000196	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTGS2—esophageal cancer	2.25e-05	0.000196	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—esophageal cancer	2.23e-05	0.000195	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CA—esophageal cancer	2.15e-05	0.000187	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CA—esophageal cancer	2.15e-05	0.000187	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTGS2—esophageal cancer	2.06e-05	0.00018	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PIK3CA—esophageal cancer	2.05e-05	0.000179	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CA—esophageal cancer	1.97e-05	0.000171	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CREBBP—esophageal cancer	1.96e-05	0.000171	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CREBBP—esophageal cancer	1.96e-05	0.000171	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—EP300—esophageal cancer	1.87e-05	0.000163	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NOS3—esophageal cancer	1.76e-05	0.000153	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NOS3—esophageal cancer	1.76e-05	0.000153	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CA—esophageal cancer	1.72e-05	0.00015	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CA—esophageal cancer	1.72e-05	0.00015	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CA—esophageal cancer	1.72e-05	0.00015	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—EP300—esophageal cancer	1.71e-05	0.000149	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTGS2—esophageal cancer	1.61e-05	0.00014	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTGS2—esophageal cancer	1.61e-05	0.00014	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CA—esophageal cancer	1.39e-05	0.000121	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—EP300—esophageal cancer	1.34e-05	0.000116	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—EP300—esophageal cancer	1.34e-05	0.000116	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CA—esophageal cancer	1.27e-05	0.00011	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CA—esophageal cancer	9.88e-06	8.61e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CA—esophageal cancer	9.88e-06	8.61e-05	CbGpPWpGaD
